Neuronal imaging using SPECT.

Area of Science:

• Cardiology
• Nuclear Medicine
• Medical Imaging

Background:

• Cardiac sympathetic dysfunction is integral to various heart conditions, impacting severity, prognosis, and treatment efficacy.
• (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is a key clinical tool for assessing cardiac sympathetic function.
• MIBG provides valuable data for heart failure, ischaemic heart disease, and arrhythmic conditions.

Purpose of the Study:

• To review the fundamental information and clinical utility of MIBG myocardial scintigraphy.
• To discuss the application of MIBG in evaluating cardiac sympathetic function across different heart diseases.
• To highlight existing challenges and future directions for MIBG scintigraphy.

Main Methods:

• Review of existing literature on MIBG myocardial scintigraphy.
• Analysis of MIBG's role in assessing cardiac sympathetic function.
• Comparison of MIBG with other imaging modalities where applicable.

Main Results:

• MIBG scintigraphy is valuable for evaluating cardiac sympathetic function in heart failure, ischaemic heart disease, and arrhythmias.
• Quantitative MIBG indices can vary between institutions, requiring standardization.
• Established evidence for MIBG in ischaemic heart disease is less robust than for myocardial perfusion imaging.

Conclusions:

• MIBG myocardial scintigraphy is a vital method for objective evaluation of cardiac sympathetic function.
• Further standardization and evidence generation are needed for widespread adoption, particularly in ischaemic heart disease.
• MIBG remains a promising tool for assessing severity, prognosis, and therapeutic effects in cardiovascular diseases.